2009
DOI: 10.1016/j.thromres.2008.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Effect of VKORC1 –1639 G>A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
32
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(35 citation statements)
references
References 29 publications
2
32
1
Order By: Relevance
“…Our findings are in concordance with previous studies carried on a Japanese [14], Chinese [41] and Indonesian population [23]. This is in contrast to other reports [7][8][9].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Our findings are in concordance with previous studies carried on a Japanese [14], Chinese [41] and Indonesian population [23]. This is in contrast to other reports [7][8][9].…”
Section: Discussionsupporting
confidence: 92%
“…Two single nucleotide polymorphisms (SNPs) of VKORC1 were found to estimate warfarin dosing phenotypes: -1639G[A (rs9923231) promoter polymorphism and 1173C[T (rs9934438) intronic polymorphism [9]. Studies of white and Asian patients have reported that CYP2C9 and VKORC1 polymorphisms influence the maintenance dose of warfarin [14,15], but they appear to contribute to less than half of the inter-individual variability in the doseresponse relationship to oral anticoagulants [14]. Several warfarin dosing algorithms have been proposed to tailor the warfarin dosing in the European, Asian and AfricanAmerican populations.…”
Section: Introductionmentioning
confidence: 99%
“…A study conducted by Yoshizawa et al showed that polymorphism CYP2C9 and vitamin K epoxide reductase complex subunit 1 (VKORC1) contribute helpfully to warfarin's efficacy and toxicity. CYP2C9 was an enzyme that was useful for warfarin metabolism, while VKORC1 was a target gene where warfarin works [11]. According to the result of a study about pharmacogenetic conducted by Taofik et al toward population of Indonesian who use warfarin, exemplifies that age and genetical variation of CYP2C9 and VKORC1 influences warfarin response, namely, the result of PT-INR, index of pharmacodynamic, index of pharmacokinetics, and S-warfarin concentration on patients who consume low-dosage warfarin (1 mg).…”
Section: Discussionmentioning
confidence: 99%
“…Inter-individual variability in dose response to warfarin is associated with various demographic, clinical, and genetic factors [20]. A number of algorithms have been developed to quantitatively predict the maintenance dose of warfarin in multiple ethnicities [21,22] including Japanese [23][24][25][26][27][28].…”
Section: Discussionmentioning
confidence: 99%